Tapentadol Liconsa 100 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA1239/029/003
Authorised: 05/08/2022
Laboratorios LICONSA, S.A.
|
SPC
PIL
|
Tapentadol Liconsa 150 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA1239/029/004
Authorised: 05/08/2022
Laboratorios LICONSA, S.A.
|
SPC
PIL
|
Tapentadol Liconsa 200 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA1239/029/005
Authorised: 05/08/2022
Laboratorios LICONSA, S.A.
|
SPC
PIL
|
Tapentadol Liconsa 25 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA1239/029/001
Authorised: 05/08/2022
Laboratorios LICONSA, S.A.
|
SPC
PIL
|
Tapentadol Liconsa 250 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA1239/029/006
Authorised: 05/08/2022
Laboratorios LICONSA, S.A.
|
SPC
PIL
|
Tapentadol Liconsa 50 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA1239/029/002
Authorised: 05/08/2022
Laboratorios LICONSA, S.A.
|
SPC
PIL
|
Tapimio 100 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA23229/005/003
Authorised: 04/11/2022
Neuraxpharm Ireland Limited
|
SPC
PIL
|
Tapimio 150 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA23229/005/004
Authorised: 04/11/2022
Neuraxpharm Ireland Limited
|
SPC
PIL
|
Tapimio 200 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA23229/005/005
Authorised: 04/11/2022
Neuraxpharm Ireland Limited
|
SPC
PIL
|
Tapimio 25 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA23229/005/001
Authorised: 04/11/2022
Neuraxpharm Ireland Limited
|
SPC
PIL
|
Tapimio 250 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA23229/005/006
Authorised: 04/11/2022
Neuraxpharm Ireland Limited
|
SPC
PIL
|
Tapimio 50 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA23229/005/002
Authorised: 04/11/2022
Neuraxpharm Ireland Limited
|
SPC
PIL
|
Taptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container
Eye drops, solution in single-dose container
Compare
|
PPA0465/475/001
Authorised: 18/06/2021
PCO Manufacturing Ltd.
|
SPC
PIL
|
Taptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container
Eye drops, solution in single-dose container
Compare
|
PA0879/003/001
Authorised: 28/11/2014
Santen OY
|
SPC
PIL
|
TAPTIQOM 15 micrograms/ml + 5 mg/ml eye drops, solution.
Eye drops, solution
Compare
|
PA0879/003/002
Authorised: 04/12/2020
Santen OY
|
SPC
PIL
|
Tarceva
Film-coated tablet
Compare
|
EU/1/05/311/01-3
Authorised: 19/09/2005
Roche Registration GmbH
|
SPC
PIL
IPAR
|
Targaxan 550 mg film-coated tablets
Film-coated tablet
Compare
|
PA1336/009/001
Authorised: 22/02/2013
Norgine B.V.
|
SPC
PIL
|
Targin 10mg/5mg prolonged-release tablets
Prolonged-release tablet
Generics List:
Oxycodone/Naloxone 10mg/5mg Prolonged Release Tablets
Compare
|
PA1688/010/002
Authorised: 06/03/2009
Mundipharma Pharmaceuticals Limited
|
SPC
PIL
|
Targin 15 mg/7.5 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA1688/010/006
Authorised: 31/01/2014
Mundipharma Pharmaceuticals Limited
|
SPC
PIL
|
Targin 20mg/10mg prolonged-release tablets
Prolonged-release tablet
Generics List:
Oxycodone/Naloxone 20mg/10mg Prolonged Release Tablets
Compare
|
PA1688/010/003
Authorised: 06/03/2009
Mundipharma Pharmaceuticals Limited
|
SPC
PIL
|